跳至主要内容
临床试验/NCT02221128
NCT02221128已完成不适用

A Post Market Surveillance Study Evaluating the Safety and Effectiveness of PerClot to Control Mild Bleeding in Subjects Undergoing Endoscopic Sinus Surgery

CryoLife Europa1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2014年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
1
主要终点
Number of subjects who achieve of haemostasis after the application of PerClot

研究概览

简要总结

A prospective, single centre, single arm study designed to collect clinical data on PerClot when used in subjects undergoing endoscopic sinus surgery.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects having Endoscopic Sinus Surgery
  • Subjects who will have PerClot used as a haemostatic agent
  • Subjects willing and able to give consent
  • Subjects over 18 years old

排除标准

  • Subjects unable or unwilling to give consent for their data to be collected

结局指标

主要结局

Number of subjects who achieve of haemostasis after the application of PerClot

时间窗: intraoperatively

次要结局

  • Number of subjects who require the use of alternative methods to achieve haemostasis after the application of PerClot(intraoperatively)

研究者

发起方
CryoLife Europa
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验